Nigella sativa added to asthma treatment in children
Part of Infections, Lungs & breathing clinical trials.
This study tests whether adding a special seed extract (Nigella sativa) to standard asthma medicine improves breathing control in children. Your child would keep their usual daily asthma meds and take an extra capsule or placebo for several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and 18 years old
- Have moderate persistent asthma (daily symptoms, need daily controller medicine)
- Be on a stable daily asthma medicine (like an inhaled steroid) for at least 4 weeks
- Be able to do a simple breathing test (spirometry)
- Not have had a severe asthma attack needing ICU care in the last 3 months
- Not have taken steroid pills or liquid in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking ginger can help people whose asthma is not well controlled with their current inhalers. If you join, you will take ginger supplements and monitor your asthma symptoms and breathing tests.
This trial tests if a daily supplement called astaxanthin can help people with mild-to-moderate asthma, especially in areas with more air pollution. You would take capsules and track your breathing at home.
This study tests a new way to help teenagers with moderate to severe asthma manage their condition better. Researchers will work with you and your doctor to create a personalized asthma action plan and see if it helps you control your symptoms and reduce flare-ups.
This trial tests if adding immune-modulating tablets (Staphylococcus and Neisseria) to standard asthma medication (budesonide formoterol) helps control asthma better. It is for people whose asthma is not well controlled despite current treatment.
This Phase 2 study checks how glycopyrronium bromide works in children with asthma, including its safety and how well inhaler dosing is tolerated. It also uses breathing tests and inhaler technique checks to confirm your child meets key asthma and lung function requirements.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.